+44 (0)20 7400 8000
Edward has specialised in intellectual property, especially patent litigation, for over 35 years. He has been responsible for almost 100 patent cases, including landmark UK decisions such as 3M v. Rennicks (validity and infringement, stay of injunction and damages), 3M v. Plastus Kreativ (cross-border injunctions), 3M v. Nippon Carbide (stay pending EPO opposition), Unilin v. B&Q (entitlement to priority, amendment, res judicata and EPO) and Servier v. Apotex (enquiry as to damages under cross-undertaking).
Beyond the UK, Edward has taken a particular interest in the development of the Unitary Patent and the Unified Patent Court (UPC). He has had the opportunity to do so through his long service on the Board of the European Lawyers Association (EPLAW). EPLAW has been very closely involved with the preparation of the legislation and the rules of procedure of the UPC and Edward has given presentations on the rules to all the leading European Patents Judges at the Venice Conferences organised jointly by EPLAW and the EPO. His work with the European Patent judiciary has included participation in “Mock Trials” conducted before these Patents Judges and already using the law and rules of the UPC. This has been a unique experience making Edward ideally qualified to advise clients on UPC issues. He has further honed his UPC skills sitting as a “Judge” in the first real-time mock trials of UPC cases which Bristows is conducting.
Edward is experienced in all technical fields, including electronics, but is particularly active in the life sciences sector, acting for some of the largest pharmaceutical, biotechnology and medical devices companies. He has developed successful strategies, combining patent and regulatory law, to assist his pharmaceutical clients facing the challenge of generics. In such matters, he has often coordinated cross-border litigation and advice within Europe and beyond. Most recently, he jointly leads a very large team successfully obtaining preliminary injunctions and other relief for originator companies such as Novartis against generic suppliers in many countries around the globe.
Edward is currently on the Advisory Board of the European Patent Lawyers Association (EPLAW) and an Associate of the Chartered Institute of Patent Agents. He is a member of the Law Society’s Intellectual Property Law Committee and the IPO’s European Practice Committee. Edward was a UK Council Member of AIPPI from 2000 to 2015.
To view Edward's practice profile click HERE